Hepatotoxicity Molecular Models
    16.
    发明申请
    Hepatotoxicity Molecular Models 审中-公开
    肝毒性分子模型

    公开(公告)号:US20110071767A1

    公开(公告)日:2011-03-24

    申请号:US11547759

    申请日:2005-04-07

    IPC分类号: G01N33/52 G01N33/48

    CPC分类号: G01N33/5014 G01N33/5067

    摘要: The present invention includes methods of predicting hepatotoxicity of test agents and methods of generating hepatotoxicity prediction models using algorithms for analyzing quantitative gene expression information. The invention also includes microarrays, computer systems comprising the toxicity prediction models, as well as methods of using the computer systems by remote users for determining the toxicity of test agents.

    摘要翻译: 本发明包括使用用于分析定量基因表达信息的算法来预测测试剂的肝毒性的方法和产生肝毒性预测模型的方法。 本发明还包括微阵列,包括毒性预测模型的计算机系统,以及由远程用户使用计算机系统来确定测试剂的毒性的方法。

    TYPE 1 INTEFERON DIAGNOSTIC
    20.
    发明申请
    TYPE 1 INTEFERON DIAGNOSTIC 审中-公开
    类型1 INTEFERON诊断

    公开(公告)号:US20120251546A1

    公开(公告)日:2012-10-04

    申请号:US13393616

    申请日:2010-09-02

    摘要: The present disclosure encompasses type-I IFN and IFNα-induced PD marker expression profiles, kits, and methods for identifying such IFNα-induced PD marker expression profiles. The type-I IFN and IFNα-induced PD marker expression profiles may also be used in, for example, methods of treating patients having a type-I IFN or IFNα-mediated disorder, methods of monitoring disease progression of patients receiving treatment with a therapeutic agent that modulates type 1 interferon activity, identifying patients as candidates to receive a therapeutic that binds to and neutralizes IFNα activity, and in diagnosing or providing a prognosis to patients having IFNα-induced disorders.

    摘要翻译: 本公开内容涵盖I型IFN和IFNα诱导的PD标志物表达谱,试剂盒和用于鉴定这种IFNα诱导的PD标志物表达谱的方法。 I型IFN和IFNα诱导的PD标志物表达谱也可用于例如治疗患有I型IFN或IFNα介导的病症的患者的方法,监测接受治疗的患者的疾病进展的方法 调节1型干扰素活性的试剂,鉴定患者作为接受结合并中和IFNα活性的治疗剂的候选物,以及诊断或提供具有IFNα诱导的病症的患者的预后。